Next Article in Journal
Systemic Therapies in Metastatic Non-Small-Cell Lung Cancer with Emphasis on Targeted Therapies: The Rational Approach
Previous Article in Journal
Management of Hot Flashes in Women with Breast Cancer
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..

Management of Aromatase Inhibitor–Induced Arthralgia

790 Commissioners Road East, London, ON N6A 4L6, Canada
Author to whom correspondence should be addressed.
Received: 7 November 2009 / Revised: 8 December 2009 / Accepted: 2 January 2010 / Published: 1 February 2010
Aromatase inhibitors (AIS) are commonly used as adjuvant treatment in postmenopausal women with hormone receptor–positive early breast cancer. With both steroidal and nonsteroidal AIS, AI-induced arthralgia is frequently observed. The mechanism of AI-induced arthralgia remains unknown, and the data available from clinical trails using AIS are limited. We review the pertinent information from a clinical perspective, including an algorithm to treat AI-induced arthralgia.
Keywords: aromatase inhibitors; arthritis; arthralgia; breast cancer aromatase inhibitors; arthritis; arthralgia; breast cancer
MDPI and ACS Style

Younus, J.; Kligman, L. Management of Aromatase Inhibitor–Induced Arthralgia. Curr. Oncol. 2010, 17, 87-90.

AMA Style

Younus J, Kligman L. Management of Aromatase Inhibitor–Induced Arthralgia. Current Oncology. 2010; 17(1):87-90.

Chicago/Turabian Style

Younus, J., and L. Kligman 2010. "Management of Aromatase Inhibitor–Induced Arthralgia" Current Oncology 17, no. 1: 87-90.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop